Tyler Egan
Physician Assistant · Williston, FLNPI 1508352915
Payments from drug & device makers
Across 132 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$615
- AbbVie$346
- Novo Nordisk$285
- Vanda Pharmaceuticals Inc.$239
- GSK$226
- Pfizer$187
- plus $561 from 12 others
What the payments were for
- Food & beverage$2,31494%
- Education$853%
- Gifts$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 37 | $615 |
| AbbVie | 18 | $346 |
| Novo Nordisk | 17 | $285 |
| Vanda Pharmaceuticals Inc. | 9 | $239 |
| GSK | 12 | $226 |
| Pfizer | 12 | $187 |
| AstraZeneca | 10 | $136 |
| Astellas Pharma US Inc | 2 | $101 |
| Mannkind Corporation | 1 | $59 |
| Boehringer Ingelheim | 2 | $55 |
| Amgen | 3 | $49 |
| Exact Sciences | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Abbott | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Insulet Corporation | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
How this compares
$2,459 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $60,549 |
| OzempicSemaglutide | 29 | $55,272 |
| TrulicityDulaglutide | 27 | $50,186 |
| JardianceEmpagliflozin | 19 | $35,888 |
| EliquisApixaban | 31 | $31,331 |
| XareltoRivaroxaban | 24 | $22,358 |
| JanuviaSitagliptin Phosphate | 18 | $22,074 |
| VraylarCariprazine Hcl | 11 | $18,433 |
| FarxigaDapagliflozin Propanediol | 16 | $17,942 |
| Spiriva RespimatTiotropium Bromide | 15 | $7,713 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 244 | $6,597 |
| Varenicline Tartrate | 22 | $3,726 |
| Omeprazole | 170 | $3,450 |
| Gabapentin | 143 | $3,416 |
| Duloxetine Hcl | 81 | $3,408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $226 | $60,54948 claims |
| Novo NordiskOzempic | $285 | $55,27229 claims |
| Lilly USA, LLCTrulicity | $615 | $50,18627 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $55 | $43,60134 claims |
| PfizerEliquis | $187 | $31,33131 claims |
| AbbVieVraylar, Synthroid | $346 | $19,93531 claims |
| AstraZenecaFarxiga | $136 | $17,94216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Williston
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.